X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2016 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
ABBOTT INDIA LIMITED (500488 | ABBOTINDIA~EQ) Detailed Financial Information - ABBOTT INDIA LIMITED Company Fact Sheet and Latest Results - Equitymaster.com
Investing in India? Get Equitymaster Research  

ABBOTT INDIA LIMITED  (KNOL)


 
abbott india - 1 Year Stock Price Chart
Loading...

 Price History
    Price Rs 4,747.0       No. of shares m 21.25
    Mkt Cap Rs m 100,874       % ch % 2.8
    Vol '000 0.2       % ch week % -0.1
    P/E X 38.1       % ch 1-mth % 0.3
    P/CF X 36.8       % ch 12-mth % -16.0
    EPS (TTM) Rs 124.7       52 week H/L Rs 6,050.0/4,360.0
(As on Sep 30, 2016 03:42:00 PM) »  Best Performing pharmaceuticals Stocks

DO YOU LIKE THESE FACTSHEETS? TELL US!
 Financials

* Results Consolidated
No. of Months
Year Ending
12
Dec-11
12
Dec-12
15
Mar-14
12
Mar-15
12
Mar-16
5-Yr Chart
Click to enlarge
  EQUITY SHARE DATA
High Rs1,6831,8071,7934,1196,015 
Low Rs1,1781,3751,3003,7003,707 
Sales per share (Unadj.) Rs701.3777.71,080.91,077.31,236.9 
Earnings per share (Unadj.) Rs56.768.193.4107.7122.2 
Diluted earnings per shareRs56.768.193.4107.7122.2 
Cash flow per share (Unadj.) Rs63.777.3103.7114.8129.0 
Dividends per share (Unadj.) Rs17.0017.0023.0031.0035.00 
Adj. dividends per shareRs17.0017.0023.0031.0035.00 
Dividend yield (eoy) %1.21.11.50.80.7 
Book value per share (Unadj.) Rs256.0304.4370.8441.2521.2 
Adj. book value per shareRs256.0304.4370.8441.2521.2 
Shares outstanding (eoy) m21.2521.2521.2521.2521.25 
Bonus/Rights/Conversions  A---- 
Price / Sales ratio x2.02.01.43.63.9 
Avg P/E ratio x25.323.416.636.339.8 
P/CF ratio (eoy) x22.520.614.934.137.7 
Price / Book Value ratio x5.65.24.28.99.3 
Dividend payout %30.025.024.628.828.6 
Avg Mkt Cap Rs m30,39833,80932,85883,079103,296 
No. of employees `0002.42.72.82.93.0 
Total wages/salary Rs m1,6732,0622,9973,0543,370 
Avg. sales/employee Rs Th6,145.26,196.88,304.07,985.18,891.8 
Avg. wages/employee Rs Th689.9773.21,083.71,065.21,140.0 
Avg. net profit/employee Rs Th496.4542.6717.5798.6878.3 
  INCOME DATA
Net Sales Rs m14,90216,52722,96922,89326,284 
Other income Rs m197223482476504 
Total revenues Rs m15,09916,75023,45123,36926,789 
Gross profit Rs m1,7552,0182,6833,1233,665 
Depreciation Rs m150195219149144 
Interest Rs m00158 
Profit before tax Rs m1,8022,0462,9463,4444,017 
Minority Interest Rs m00000 
Prior Period Items Rs m-430000 
Extraordinary Inc (Exp) Rs m0104000 
Tax Rs m5557039611,1541,421 
Profit after tax Rs m1,2041,4471,9852,2902,596 
Gross profit margin %11.812.211.713.613.9 
Effective tax rate %30.834.432.633.535.4 
Net profit margin %8.18.88.610.09.9 
  BALANCE SHEET DATA
Current assets Rs m6,8637,7399,96512,26114,446 
Current liabilities Rs m2,3852,29630,6123,9694,725 
Net working cap to sales %30.032.9-89.936.237.0 
Current ratio x2.93.40.33.13.1 
Inventory Days Days6258576151 
Debtors Days Days3231172120 
Net fixed assets Rs m8001,0929951,0001,113 
Share capital Rs m212213213213213 
"Free" reserves Rs m5,1736,2007,6109,10710,808 
Net worth Rs m5,4416,4697,8799,37511,076 
Long term debt Rs m00000 
Total assets Rs m7,9139,07111,39213,73616,241 
Interest coverage xNM10,231.03,682.9689.7497.0 
Debt to equity ratio x00000 
Sales to assets ratio x1.91.82.01.71.6 
Return on assets %15.216.017.416.716.0 
Return on equity %22.122.425.224.423.4 
Return on capital %32.333.237.436.836.3 
Exports to sales %0.40.70.60.50.6 
Imports to sales %7.910.715.99.912.6 
Exports (fob) Rs m59120141122162 
Imports (cif) Rs m1,1761,7643,6592,2643,322 
Fx inflow Rs m113179240215268 
Fx outflow Rs m1,5172,1174,0412,7373,927 
Net fx Rs m-1,404-1,937-3,801-2,523-3,659 
  CASH FLOW
From Operations Rs m 241 1,014 1,545 2,148 2,514 
From Investments Rs m 51 -585 -1,431 -1,867 -800 
From Financial Activity Rs m -420 -420 -424 -576 -803 
Net Cashflow Rs m -129 8 -309 -295 912 
* Results Consolidated Source: Company Annual Reports, Regulatory Filings, Equitymaster »  Historical quarterly results for abbott india limited

 Share Holding
Indian Promoters : 0.0%
Foreign collaborators : 75.0%
Indian inst/Mut Fund : 7.9%
FIIs : 0.1%
ADR/GDR : 0.0%
Free float : 17.1%
Shareholders : 18,270
Pledged promoter(s) holding : 0.0%
 Company Information
Top
    REGD OFF: 3-4, Corporate Park, Sion Trombay Road, Mumbai - 400 071
    E-MAIL: investor.relations@abbott.co.in     WEB: www.abbott.co.in
    TELEPHONE: (022) 6797 8888     FAX: (022) 6797 8727
    SECTOR: PHARMACEUTICALS     GROUP: M N C
    TR AGENT: Sharepro Serv., 13 AB, Samhita Warehousing, 2nd Flr, Andheri (E), Mumbai-72
    AUDITOR: Deloitte Haskins & Sells
CHM: Munir Shaikh COMP SEC: Krupa Anandpara YEAR OF INC: 1944 BSE CODE: 500488 FV (Rs): 10 DIV YIELD (%): 0.7

More pharmaceuticals Company Fact Sheets:   FULFORD INDIADR. REDDYS LABWYETH LTDINDOCO REMEDIESCIPLA

Views on news

Biocon: Lower R&D Expenses Help Margin Expansion (Quarterly Results Update - Detailed)

Sep 19, 2016

Biocon has announced its 1QFY17. The company has reported 21.1% YoY growth in total income and 34.6% YoY increase in net profits. Here is our analysis of the results.

Cipla: Weak Quarter, Positive Triggers Ahead (Quarterly Results Update - Detailed)

Sep 19, 2016

Cipla has announced its results for the June quarter (1QFY17) results. The company has reported a decline of 6.4% YoY in sales while profits were down by 43.7% YoY.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Dr Reddy's: Major Business Segments Come Under Pressure (Quarterly Results Update - Detailed)

Sep 12, 2016

Dr Reddy's has announced the results for first quarter of FY17 (1QFY17). The company has reported decline in the sales by 13.9% YoY while net profits declined by 79.8 % YoY.

Sun Pharma: US Segment Shows Signs of Improvement (Quarterly Results Update - Detailed)

Sep 12, 2016

Sun Pharma has announced its 1QFY17 results. The company has reported 22.7% YoY growth in sales and a growth of 266% in the net profits. Here is our analysis of the results.

More Views on News

Most Popular

Are You Ready for the 2017 Recession?(Vivek Kaul's Diary)

Sep 17, 2016

Sooner or later, the recovery myth will explode...

Buffett Owes His US$67 Billion Net Worth to These Three Words(The 5 Minute Wrapup)

Sep 22, 2016

The three words that made the biggest contribution to Warren Buffett's enormous wealth.

Asset Quality of PSBs Still Below Par(Chart Of The Day)

Sep 17, 2016

Structured Debt Restructuring not a cakewalk for banks.

Should You Worry About How Much Your Fund Manager Earns?(Outside View)

Sep 19, 2016

PersonalFN explains why instead of focusing merely on how much your fund manager earns, a holistic assessment is imperative to select mutual funds prudently for your investment portfolio.

Discretionary versus System Trading(Daily Profit Hunter)

Sep 23, 2016

Most trading strategies are either discretionary or system based. Both have their pros and cons. System trading is easier to implement, and the best option for new traders

More

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ABBOTT INDIA

ABBOTT INDIA 8-QTR ANALYSIS

Detailed Quarterly Results With Charts

COMPARE ABBOTT INDIA WITH

MARKET STATS